We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Neuroscience Research to Benefit from 3-D Printing of Brain-Like Structures

By LabMedica International staff writers
Posted on 12 Aug 2015
Advanced three-dimensional printing techniques were used to generate a biological construct that incorporated neural cells and mimicked brain cell activities for use in applications ranging from cell behavior studies to improving understanding of brain injuries and neurodegenerative diseases.

Researchers have attempted to study the brain by modeling the architecture using two dimensional (2-D) in vitro cell culturing methods. More...
While those platforms attempt to mimic the in vivo environment, they do not truly resemble the three dimensional (3-D) microstructure of neuronal tissues. Development of an accurate in vitro model of the brain remains a significant obstacle to understanding the functioning of the brain at the tissue or organ level.

Investigators at the ARC Centre of Excellence for Electromaterials Science (North Wollongong, NSW, Australia) applied a 3-D printing approach to the problem of developing a useful in vitro brain model. They reported in the July 14, 2015, online edition of the journal Biomaterials that they had developed a new method to bioprint 3-D brain-like structures consisting of discrete layers of primary neural cells encapsulated in hydrogels.

Brain-like structures were constructed with a Stratasys Ltd. (Rehovot, Israel) Connex Objet350 3D printer using a bio-ink consisting of a novel peptide-modified biopolymer, gellan gum-RGD (RGD-GG), combined with primary cortical neurons. The ink was optimized for a modified reactive printing process and developed for use in traditional cell culturing facilities without the need for extensive bioprinting equipment. Furthermore, the peptide modification of the gellan gum hydrogel was found to have a profound positive effect on primary cell proliferation and network formation. Neural cell viability combined with the support of neural network formation demonstrated the cell supportive nature of the matrix.

"This study highlights the importance of integrating advances in 3-D printing, with those in materials science, to realize a biological outcome," said senior author Dr. Gordon Wallace, head of the ARC Centre of Excellence for Electromaterials Science.

"This paves the way for the use of more sophisticated printers to create structures with much finer resolution. We are still a long way from printing a brain but the ability to arrange cells so as they form neuronal networks is a significant step forward."

Related Links:

ARC Centre of Excellence for Electromaterials Science
Stratasys Ltd.



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Clinical Chemistry System
P780
Automatic Hematology Analyzer
DH-800 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.